WindRose Health Investors Recapitalizes Healthmap Solutions

WindRose Health Investors Recapitalizes RevHealth

July 27, 2022

Healthcare Services

WindRose Health Investors completed a recapitalization of RevHealth, a Morristown, New Jersey-based omnichannel healthcare communications agency. The investment will provide capital to support RevHealth's growth and expansion of services; founders Bruce Epstein, Bruce Medd, and Brian Wheeler will continue to lead the company and remain significant shareholders.

WindRose Health Investors Recapitalizes Lykan Bioscience Holdings

June 4, 2019

Biotechnology

WindRose Health Investors completed an equity recapitalization of Lykan Bioscience Holdings, LLC, a Hopkinton, Massachusetts-based contract manufacturing services organization focused on cell and gene therapy production and logistics. The investment provides capital to support growth and the build-out of a 60,000+ square foot cGMP facility to expand manufacturing capacity; terms were not disclosed.

WindRose Health Investors Recapitalizes Bluestone Physician Services

April 14, 2021

Healthcare Services

WindRose Health Investors completed an equity recapitalization of Bluestone Physician Services to provide growth capital and support expansion. Bluestone — a provider of on-site primary care, care coordination, and behavioral health services for high-risk, geriatric and disabled patients — will continue to be led by founder Dr. Todd Stivland, who and the executive team retain a significant minority stake.

WindRose Health Investors Recapitalizes Terrapin Pharmacy

January 5, 2022

Healthcare Services

WindRose Health Investors completed a recapitalization of Terrapin Pharmacy LLC, a closed-door specialty pharmacy serving behavioral health and long-term care populations in the Mid-Atlantic. The investment provides growth capital to support geographic expansion and increased market share; terms were not disclosed.

WindRose Health Investors Recapitalizes Veristat Group Inc.

April 7, 2021

Healthcare Services

WindRose Health Investors completed an equity recapitalization of Veristat Group Inc., a global clinical research organization, with Veristat management retaining a significant minority stake. The investment will provide capital and strategic resources to support Veristat's growth and expansion across clinical development, regulatory affairs, biostatistics, data management and pharmacovigilance; terms were not disclosed.

Court Square Capital Partners and WindRose Health Investors Recapitalize Soleo Health

February 3, 2025

Healthcare Services

Court Square Capital Partners and WindRose Health Investors announced a jointly controlled recapitalization of Soleo Health, a Frisco, Texas-based provider of specialty pharmacy and infusion services. The investment will provide capital to scale Soleo's national footprint (26 pharmacies, 30+ infusion suites) and support growth across all 50 states while partnering with the company's founders and management team.